InsidersTradesSigma
Explore the full record of transactions filed by SCHIFF ANDREW N, Director. Director active across 1 companies, notably Aclaris Therapeutics, Inc.. Cumulatively, 2 disclosures have been published. Total volume traded: €281k. The latest transaction was filed on 17 June 2022 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Andrew N. Schiff is a Board Member at Aclaris Therapeutics, Inc., a biopharmaceutical company focused on developing treatments for dermatological diseases. As a board member, he participates in overseeing the company's strategies and making key decisions. Andrew brings expertise in biotechnology and drug development.